Algert Global’s Precision BioSciences DTIL Stock Holding History

Algert Global’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-911	Closed	-$380K	–	437
2019 Q4	$380K	Buy	+911	New	+$286K	0.11%	238

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

ACWM

Adams Chetwood Wealth Management Durham, North Carolina $176M AUM 8.48% 1-Year Est. Return

Algert Global's DTIL Position: Q1 2020 in Review

Algert Global sold out of Precision BioSciences (DTIL) in Q1 2020, closing a stake of 911 shares — an estimated $380K sold.

Algert Global first reported a position in DTIL in Q4 2019 and held it in 1 quarter. The position peaked at $380K in Q4 2019. 109 funds tracked by Wall St. Rank hold DTIL as of Q1 2020.

Algert Global reported no remaining Precision BioSciences position as of Q1 2020 after selling out during the quarter.
Algert Global sold 911 Precision BioSciences shares in Q1 2020, an estimated $380K.
Algert Global first reported a position in Precision BioSciences in Q4 2019 and held it in 1 quarter.
Algert Global's Precision BioSciences position peaked at $380K in Q4 2019.
109 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2020.

Based on Algert Global's 13F filing for Q1 2020, filed 13 May 2020.